Human Gene Therapy : Impact Factor & More
eISSN: 1557-7422pISSN: 1043-0342
Share this on:
Key Metrics
CiteScore 
8.2
Eigenfactor
0.005 - 0.01
H-Index
156
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Human Gene Therapy
Human Gene Therapy Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Human Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Human Gene Therapy
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors.
- 20 May 2026
- Human gene therapy
The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis.
- 14 May 2026
- Human gene therapy
FDA Issues Plausible Mechanism Pathway Draft Guidance.
- 1 May 2026
- Human gene therapy
Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.
- 1 May 2026
- Human gene therapy
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study.
- 28 Apr 2026
- Human gene therapy
Strategies and Advances in Site-Specific Integration of Exogenous Large Genes.
- 24 Apr 2026
- Human gene therapy
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors.
- 20 May 2026
- Human gene therapy
The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis.
- 14 May 2026
- Human gene therapy
FDA Issues Plausible Mechanism Pathway Draft Guidance.
- 1 May 2026
- Human gene therapy
Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.
- 1 May 2026
- Human gene therapy
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study.
- 28 Apr 2026
- Human gene therapy
Strategies and Advances in Site-Specific Integration of Exogenous Large Genes.
- 24 Apr 2026
- Human gene therapy
FAQs on Human Gene Therapy
How long has Human Gene Therapy been actively publishing? 
What is the publishing frequency of Human Gene Therapy?
How many articles did Human Gene Therapy publish last year?
What is the eISSN & pISSN for Human Gene Therapy?
What is Citescore for Human Gene Therapy?
What is the H Index for Human Gene Therapy ?
What is SNIP score for Human Gene Therapy?
What is the SJR for Human Gene Therapy?
Who is the publisher of Human Gene Therapy?
